Organon (MEX:OGN) Preferred Dividends : MXN0 Mil (TTM As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Organon Preferred Dividends?

Preferred dividend is a dividend that is accrued and paid on a company's preferred shares. Organon's preferred dividends for the three months ended in Sep. 2024 was MXN0 Mil. Its preferred dividends for the trailing twelve months (TTM) ended in Sep. 2024 was MXN0 Mil.

Organon Preferred Dividends Historical Data

The historical data trend for Organon's Preferred Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Organon Preferred Dividends Chart

Organon Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Preferred Dividends

Get a 7-Day Free Trial

Organon Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Preferred Dividends	Get a 7-Day Free Trial															-	-	-	-	-

Organon Preferred Dividends Calculation

A dividend that is accrued and paid on a company's preferred shares.

Organon (MEX:OGN) Preferred Dividends Explanation

In the event that a company is unable to pay all dividends, claims to preferred dividends take precedence over claims to dividends that are paid on common shares.

Preferred Dividends for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN0 Mil.

Organon Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Organon & Co (MEX:OGN) » Definitions » Preferred Dividends

Comparable Companies

Traded in Other Exchanges

OGN:USA 1OGN:Italy 7XP:Germany

Address

30 Hudson Street, Floor 33, Jersey City, NJ, USA, 07302

Website

https://www.organon.com

Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.